In-stent restenosis of drug-eluting stents-Reference-Cited by-同舟云学术

In-stent restenosis of drug-eluting stents

Published:2013-09 Issue:5 Volume:9 Page:721-731
ISSN:1479-6678
Container-title:Future Cardiology
language:en
Short-container-title:Future Cardiology

Author:

Minha Sa’ar¹²,Pichard Augusto D¹²,Waksman Ron²³

Affiliation:

1. Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA

2. MedStar Washington Hospital Center, 110 Irving Street, NW, Suite 4B-1, Washington, DC 20010, USA

3. Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA. .

Abstract

Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic dilemma. Recent insights regarding the patho-physiological processes and therapeutic alternatives have added to the accumulated knowledge regarding the appropriate approach to this phenomenon. This review aims to detail the mechanism and clinical presentation of, and therapeutic strategies for, the treatment of DES in in-stent restenosis.

Publisher

Future Medicine Ltd

Subject

Cardiology and Cardiovascular Medicine,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fca.13.45

Reference63 articles.

1. A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease

2. A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

3. Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

4. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels

5. In-Stent Restenosis in the Drug-Eluting Stent Era

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Copper nanoparticles green-formulated by a medicinal plant: Preparation, characterization and investigation of its cardioprotective effects;Inorganic Chemistry Communications;2023-09

2. An in-depth review of retrospective studies to assess the role of vascular brachytherapy for the treatment of complex patients with multiple risk factors for DES-ISR;Reviews in Cardiovascular Medicine;2022-02-09

3. Effects of TCFA on stent neointimal coverage at 9 months after EXCEL drug-eluting stent implantation assessed by OCT;Herz;2022-01-03

4. lncRNA MALAT1/miR-143 axis is a potential biomarker for in-stent restenosis and is involved in the multiplication of vascular smooth muscle cells;Open Life Sciences;2021-01-01

5. Assessment of female sex in preclinical vascular models;Vascular Disease in Women;2021